載入...
Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of Small Cell Lung Cancer
With the in-depth study of tumor immunity, immunotherapy represented by immune checkpoint inhibitors has made a great breakthrough in solid tumors. Small cell lung cancer (SCLC) accounts for about 15%-20% of all lung cancers, with high malignancy, early metastasis and lack of effective treatment str...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Chinês |
| 出版: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-04-01
|
| 叢編: | Chinese Journal of Lung Cancer |
| 主題: | |
| 在線閱讀: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.07 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|